The effects of chemotherapeutic drugs on viabilty, apoptosis, and survivin expression in MCF-7 cells

Acta Histochemica et Cytochemica

Volumn 38, Issue 5, 2005, Pages 323-330

  Al Joudi, Fawwaz Shakir ^a   Alias, Iskandar Zulkarnain ^a   Samsudin, Abdul Rani ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

Apoptosis; MCF 7 cells; Survivin; Viability

Indexed keywords

ACRIDINE ORANGE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; DYE; FLUOROURACIL; PROPIDIUM IODIDE; SURVIVIN; TAMOXIFEN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL STRAIN MCF 7; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CYTOPLASM; DRUG EFFECT; EVALUATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INCUBATION TIME; NITROBLUE TETRAZOLIUM TEST; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 28444456685     PISSN: 00445991     EISSN: 13475800     Source Type: Journal    
DOI: 10.1267/ahc.38.323     Document Type: Article

References (26)

1. Al-Joudi, F. S. and Iskandar, Z. A. (2004) Development of an immunohistochemical assay for the detection of survivin using selected oligopeptides and comparing two immunization protocols. Proceedings of the 9th National Conference on Medical Sciences, Kota Bharu, Malaysia, 22-23rd May.
2. Altieri, D. C. and Marchisio, C. (1999) Survivin apoptosis: An interloper between cell death and cell proliferation in cancer. Lab. Invest. 79; 1327-1333.
3. Ambrosini, G., Adida, C., Sirugo, G. and Altieri, D. C. (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273; 11177-11182.
4. Frankfurt, O. S., Sugarbaker, E. V., Robb, J. A. and Villa, L. (1995) Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett. 97; 149-154.
5. Freshney, R. I. (2000) Culture of Animal Cells. A Manual of Basic Technique. 4th ed., John Wiley & Sons, Inc., New York, Chichester, Weinheim, Brisbane, Singapore, Toronto.
6. Gompel, A., Chaouat, M., Hugol, D. and Forgez, P. (2000) Steroidal hormones and proliferation, differentiation, and apoptosis in breast cells. Euro Menopause J. 18; 1-9.
7. Grossman, D., McNiff, J. M., Li, F. and Altieri, D. C. (1999) Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J. Invest. Dermatol. 113; 1076-1081.
8. Jassem, J., Pienkowski, T., Pluzanska, A., Jelic, S., Gorbunova, V., Mrsic-Krmpotic, V., Berzins, J., Nagykalnai, T., Wigler, N., Renard, J., Munier, S. and Weil, C. (2001) Doxorubicin and paclitaxel improve survival compared with fluorouracil, doxorubicin and cyclophosphamide for women with metastatic breast cancer. Evidence-based Oncology 2; 2002-2004.
9. Kaufmann, S. H. and Earnshaw, W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256; 42-49.
10. Koechli, O. R., Sevin, B. U., Perras, J. M., Angioli, R., Untch, M., Steren, A., Ramachandran, C. and Averette, H. E. (1994) Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay. Oncology 51; 552-558.
11. Kottke, T. J., Blajeski, A. L., Martins, L. M., Mesner, P. W., Davidson, N. E., Earnshaw, W. C., Armstrong, D. K. and Kaufmann, S. H. (1999) Comparison of paclitaxel-, 5-fluoro-2′-deoxyuridine-, and epidermal growth factor (EGF)-induced apoptosis. J. Biol. Chem. 274; 15927-15936.
12. Mesri, M., Wall, N. R., Li, J., Kim, R. W. and Altieri, D. C. (2001) Cancer gene therapy using a survivin mutant adenovirus. J. Clin. Invest. 108; 981-990.
13. Papadimitriou, C. S., Costopoulus, J. S., Christoforidou, B. P., Kotsianti, A. J., Karkavelas, G. S., Hytriroglou, P. M., Koufogiannis, D. J. and Nenopoulou, H. E. (1997) Expression of bcl-2 protein in human primary breast carcinomas and its correlation with multifocality, histopathological types and prognosis. Eur. J. Cancer 33; 1275-1280.
14. Parisot, J. P., Hu, X. F., DeLuise, M. and Zalcberg, J. R. (1999) Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line. Br. J. Cancer 79; 693-700.
15. Renehan, A. G., Booth, C. and Potten, C. S. (2001) What is apoptosis, and why is it important. BMJ 322; 1536-1538.
16. Rodel, C., Haas, J., Groth, A., Grabenbauer, G. G., Saauer, R. and Rodel, F. (2003) Spontaeous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor. Int. J. Radiat. Oncol. Biol. Phys. 55; 1341-1347.
17. Rodriguez, J. A., Span, S. W., Ferreira, C. G. M., Kruyt, F. A. E. and Giaccone, G. (2002) CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp. Cell Res. 275; 44-53.
18. Salami, S. and Karami-Tehrani, F. (2003) Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin. Biochem. 36; 247-253.
19. Shankar, S. L., Mani, S. and O'Guin, K. N. (2001) Survivin, inhibition induces human neural tumor cell death through caspases-independent and dependent pathways. J. Neurochem. 79; 426-436.
20. Sui, L., Dong, Y., Ohno, M., Watanabe, Y., Sugimoto, K. and Tokuda, M. (2002) Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int. J. Oncol. 21; 315-320.
21. Tanaka, K., Iwamoto, S., Gon, G., Nohara, T., Iwamoto, M. and Tanigawa, N. (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6; 127-134.
22. Tanaka, T., Uchida, H., Sasaki, K., Miyagishi, M., Taira, K. and Hamada, H. (2004) Adenovirus-mediated siRNA against survivin enhanced sensitivity to paclitaxel-induced apoptosis in MCF-7 cells. Mol. Ther. 9 (Suppl 1); 292-293.
23. Uren, A. G., Pakush, M., Burke, R. and Vaux, D. L. (2000/2001) Cell division function of human survivin and its homologues in diverse eukaryotes. The Walter and Eliza Hall Institute of Medical Research Annual Report 2000/2001.
24. Vakkala, M., Paakko, P. and Soini, Y. (1999) Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br. J. Cancer 81; 592-599.
25. Yamamoto, T., Manome, Y., Nakamura, M. and Tanigawa, N. (2002) Down regulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer. Eur. J. Cancer 38; 2316-2324.
26. L, without alteration of p53 protein levels. Clin. Cancer Res. 5; 2971-2977.